![Louise Rodino-Klapac](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 980 515 $ al 30/06/2026
Fundadora de Myonexus Therapeutics, Louise Rodino-Klapac forma parte del consejo de Alliance for Regenerative Medicine y Aavantibio, Inc. y es Directora Científica y Vicepresidenta Ejecutiva de Sarepta Therapeutics, Inc. y miembro de la Academia Americana de Neurología y de la Sociedad Americana de Terapia Génica y Celular. Anteriormente ocupó el cargo de Directora Científica en Myonexus Therapeutics, Inc. y Directora del Laboratorio de Investigación de Terapia Génica en el Hospital Infantil de la Nación. Se licenció en el King's College (Pensilvania) y se doctoró en la Universidad Estatal de Ohio.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 08/04/2026 | 54.564 ( 0,05 % ) | 980 515 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 14/12/2020 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Director/Miembro de la Junta | 01/01/2021 |
American Society of Gene & Cell Therapy
 American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services Operates as medical and professional organization that represents researchers and scientists devoted to the discovery | Corporate Officer/Principal | - |
American Academy of Neurology
 American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services Operates a professional society which represents neurologists and neuroscientists | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
Nationwide Children's Hospital
 Nationwide Children's Hospital Hospital/Nursing ManagementHealth Services Operates children's hospitals | Corporate Officer/Principal | 01/06/2019 |
Myonexus Therapeutics, Inc.
 Myonexus Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for limb-girdle muscular dystrophies | Fundador | 01/04/2019 |
Aavantibio, Inc.
 Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
King's College (Pennsylvania)
 King's College (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Academy of Neurology
American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services Operates a professional society which represents neurologists and neuroscientists | Commercial Services |
Nationwide Children's Hospital
Nationwide Children's Hospital Hospital/Nursing ManagementHealth Services Operates children's hospitals | Health Services |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services Operates as medical and professional organization that represents researchers and scientists devoted to the discovery | Commercial Services |
Myonexus Therapeutics, Inc.
Myonexus Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for limb-girdle muscular dystrophies | Health Technology |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
